SEC 13F Intelligence

Managers / Q4 2023 · view latest →

Endurant Capital Management LP

CIK 0001633055 · 66 BOVET ROAD, SUITE 353, SAN MATEO, CA, 94402 · 650-539-5905

Reported Value
$17M
Q4 2023
Positions
25
Filings on Record
24
2019–present window
Filed
Feb 14, 2024
original filing

Summary

Endurant Capital Management LP reported $17M in U.S.-listed holdings across 25 positions for Q4 2023.

Its largest position, BSX, represents 13.0% of the portfolio.

Compared with Q3 2023, the fund opened 9 new positions and exited 27.

Portfolio Metrics

Turnover
+8.8%
vs prior filed quarter
Top-10 Concentration
+70.1%
share of reported value
Largest Position
+13.0%
Boston Scientific
New / Exited
9 / 27
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $189MQ4 ’18Q1 ’19: $253MQ2 ’19: $254MQ3 ’19: $279MQ3 ’19Q4 ’19: $317MQ1 ’20: $221MQ2 ’20: $1.8BQ2 ’20Q3 ’20: $338MQ4 ’20: $277MQ1 ’21: $384MQ1 ’21Q2 ’21: $364MQ3 ’21: $439MQ4 ’21: $414MQ4 ’21Q1 ’22: $380MQ2 ’22: $285MQ3 ’22: $307MQ3 ’22Q4 ’22: $246MQ1 ’23: $195MQ2 ’23: $115MQ2 ’23Q3 ’23: $111MQ4 ’23: $17MQ1 ’24: $0Q1 ’24filingsflow.com

Portfolio Composition

By security type
Common Stock: 83.8%Other: 14.6%REIT: 1.6%
  • Common Stock · 83.8% · $15M
  • Other · 14.6% · $3M
  • REIT · 1.6% · $285,643

Quarter-over-Quarter Changes full breakdown →

vs Q3 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
AXNX*AXONICS INCNEW+24.9K24.9K+$2M$2M
ICON PLCNEW+3.7K3.7K+$1M$1M
LABORATORY CORP AMER HLDGSNEW+4.0K4.0K+$905,523$905,523
EHCENCOMPASS HEALTH CORPNEW+12.9K12.9K+$858,686$858,686
PFEPFIZER INCNEW+15.8K15.8K+$454,594$454,594
AG8AGILENT TECHNOLOGIES INCNEW+1.9K1.9K+$264,157$264,157
FTREFORTREA HLDGS INCNEW+7.0K7.0K+$243,881$243,881
QIAGEN NVNEW+5.2K5.2K+$226,661$226,661

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2023

25 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1BSXBOSTON SCIENTIFIC CORPhistory →COM12.96%$2M39.1K
2TMOTHERMO FISHER SCIENTIFIC INChistory →COM11.55%$2M3.8K
3AXNX*AXONICS INChistory →COM8.87%$2M24.9K
4ELVELEVANCE HEALTH INChistory →COM7.10%$1M2.6K
5ICON PLCSHS5.94%$1M3.7K
6LABORATORY CORP AMER HLDGSCOM NEW5.19%$905,5234.0K
7EHCENCOMPASS HEALTH CORPhistory →COM4.92%$858,68612.9K
8PODDINSULET CORPhistory →COM4.86%$847,5243.9K
9HO1HOLOGIC INChistory →COM4.76%$831,03511.6K
10ZBHZIMMER BIOMET HOLDINGS INChistory →COM3.94%$687,1185.6K
11AVTRAVANTOR INChistory →COM3.22%$561,57224.6K
12THCTENET HEALTHCARE CORPhistory →COM NEW3.16%$551,8887.3K
13PFEPFIZER INChistory →COM2.61%$454,59415.8K
14BMRNBIOMARIN PHARMACEUTICAL INChistory →COM2.57%$448,3534.7K
15KIDSORTHOPEDIATRICS CORPhistory →COM2.50%$436,54413.4K
16CITHE CIGNA GROUPhistory →COM2.38%$414,4391.4K
17QDELQUIDELORTHO CORPhistory →COM2.17%$379,3345.1K
18COOPER COS INCCOM NEW2.14%$373,899988
19SBCSABRA HEALTH CARE REIT INChistory →COM1.64%$285,64320.0K
20AG8AGILENT TECHNOLOGIES INChistory →COM1.51%$264,1571.9K
21FTREFORTREA HLDGS INChistory →COMMON STOCK1.40%$243,8817.0K
22QIAGEN NVSHS NEW1.30%$226,6615.2K
23HUMHUMANA INChistory →COM1.23%$214,713469
24ABGCENCORA INChistory →COM1.17%$203,326990
25ACRSACLARIS THERAPEUTICS INCCOM0.89%$155,820148.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2024$01May 7, 202413F-HRchanges · EDGAR ↗
Q4 2023$17M25Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$111M43Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$115M34Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$195M50May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$246M55Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$307M49Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$285M50Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$380M63May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$414M68Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$439M53Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$364M57Aug 27, 2021RESTATEMENTchanges · EDGAR ↗
Q1 2021$384M61May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$277M52Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$338M60Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.8B56Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$221M51May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$317M54Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$279M49Nov 25, 2019RESTATEMENTchanges · EDGAR ↗
Q2 2019$254M50Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$253M70May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$189M48Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.